Trucheck™ Intelli is a blood test that can detect over 70+ cancers in asymptomatic individuals.

Trucheck Intelli is a blood-based Multi-Cancer screening test that can detect over 70+ cancers in asymptomatic individuals.

Melanoma, Head and Neck, Salivary Gland, Thyroid, Lung, Breasts, Liver, Biliary Tract, Gastro-Intestinal, Soft Tissue and Osteosarcomas, Mesothelioma, Urinary Tract, Gynaecological, Male Cancers including Prostate, CNS, Thymus, Adrenal, Skin.

Trucheck™ intelli can distinguish ~70 types of solid tumours which account for ~81% of all cancer cases and ~84% of all cancer-related deaths in Europe.

Criteria to take test:

  • Women and men above 40 years of age, who have never been diagnosed with any cancer.
  • Totally asymptomatic at present
  • No prior history of diagnosis or treatment of any cancer
  • No clinical or radiological suspicion of cancer at present
Trucheck™ Intelli blood test
individuals

57,000

Individuals Tested & Validated

sensitivity

88.2%

Sensitivity

accuracy

96.8%

Accuracy

Custom icon

A Revolutionary Blood Test To Detect Cancer Early, So That It Could Be Cured

Custom icon
What is Trucheck ™?

A prescription blood test that can help detect cancers based on presence of Circulating Tumor Cells (CTCs), which are cancer cells that enter the blood stream.

Custom icon
Who is it For?

Trucheck™ is designed for asymptomatic adult males and females, as a preventative measure to identify if there is early stage cancer present in their body.

Custom icon
How it Works?

Blood samples are evaluated for presence of circulating tumor cells (CTCs) which may be further analyzed to determine the organ or tissue of origin.

Custom icon
Why should I get Checked?

Screening is not available for all cancers. Where available, it may be an inconvenient procedure. Trucheck™ requires only a blood draw to detect underlying cancer.

Advantages of Trucheck™

Non-invasive, safe, convenient, and patient-friendly.

No need for hospitalization/visit to an advanced healthcare facility.

No inconveniences, and no procedural risks.

Can improve the early detection of cancers for which standard screening is available.

Can help early detection of cancers for which no screening is offered.

No exposure to radiation.

FAQ

  • Women and men above 40 years of age, who have never been diagnosed with any cancer.
  • Totally asymptomatic at present
  • No prior history of diagnosis or treatment of any cancer
  • No clinical or radiological suspicion of cancer at present

A positive Trucheck™ suggests detection of CTCs in the sample, suggesting a higher risk of cancer detection.

Trucheck™ is not intended to be and should not be considered as a replacement for any Standard of Care screening tests.

Within the limits of error, a ‘negative’ result is a reasonable indication of undetectable cancer of the type covered by the test. For other cancers not covered by the test, no inference should be drawn from a ‘negative’ result.

A ‘negative’ results means that at the time of the test there were no detectable cancer cells circulating in the blood.

As Trucheck™ is a non-invasive blood test, there is no disadvantage in frequent testing. However, we advise that Trucheck™ should be performed every 12 months in case of every negative result.

The test indicates the location for the select types of cancers with high accuracy, and in others the Tissue of Origin can be identified with reasonable accuracy. In all cases of ‘positive’ results, our Medical Director will create a personalised care pathway for you for further diagnostic procedures.

No, such individuals should seek expert medical advice without delay.